These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2906854

  • 1. [Study of the prevalence of tardive dyskinesia among psychiatric inpatients].
    Zhang LD.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Aug; 21(4):232-5, 255-6. PubMed ID: 2906854
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of tardive dyskinesia in private psychiatric inpatients.
    Arisco JP, Holden LD.
    Tex Med; 1989 Jan; 85(1):25-8. PubMed ID: 2564217
    [Abstract] [Full Text] [Related]

  • 3. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM.
    J Clin Psychiatry; 2004 Dec; 65 Suppl 9():16-20. PubMed ID: 15189107
    [Abstract] [Full Text] [Related]

  • 5. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 4():15-20. PubMed ID: 10739326
    [Abstract] [Full Text] [Related]

  • 6. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 7. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM, Annable L, Bélanger MC, Chouinard G.
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [Abstract] [Full Text] [Related]

  • 8. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 9. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
    Raja M, Azzoni A.
    Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
    [Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia in chronic schizophrenic inpatients.
    Kua EH, Ang PC, Siew HC.
    Singapore Med J; 1982 Feb; 23(1):19-21. PubMed ID: 6126008
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J.
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [Abstract] [Full Text] [Related]

  • 13. No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia.
    Ivanova SA, Al Hadithy AF, Brazovskaya N, Semke A, Wilffert B, Fedorenko O, Brouwers JR, Loonen AJ.
    Hum Psychopharmacol; 2012 May; 27(3):334-7. PubMed ID: 22585593
    [Abstract] [Full Text] [Related]

  • 14. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):761-4. PubMed ID: 18201810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
    Ganzini L, Heintz RT, Hoffman WF, Casey DE.
    Arch Gen Psychiatry; 1991 Mar 01; 48(3):259-63. PubMed ID: 1671743
    [Abstract] [Full Text] [Related]

  • 19. Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Hanus H, Tůtma I, Zapletálek M, Fusek J, Hrdina V.
    Homeost Health Dis; 1991 Mar 01; 33(5-6):301-4. PubMed ID: 18265509
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.